OBJECTIVE: Anxiety and depression after stroke are frequent, but are often overlooked and not assessed. The aims of the study were to (1) assess the prevalence of anxiety and depression and (2) compare the performance of the Hospital Anxiety and Depression Scale (HADS) and Montgomery and Asberg Depression Rating Scale (MADRS) as screening instruments for anxiety and depression disorders 4 months after stroke. METHODS: Stroke patients, consecutively admitted to a stroke unit, were assessed with HADS and MADRS 4 months after stroke (n=104). Depression and anxiety disorders were diagnosed using the Structured Clinical Interview for DSM-IV (SCID). Measures were compared in terms of correlations, sensitivity, specificity, positive and negative predictive value, overall agreement, kappa, and ROC curves, using DSM-IV diagnoses of "at least one current significant anxiety disorder" (Anxiety) and "any current depression" (Depression), as the clinical criteria. RESULTS: Anxiety occurred in 23% of patients and Depression in 19% (13% major depression, 3% minor depression, 4% dysthymia). For Anxiety, the optimal screening cut-off was 4 for HADS-A and 6 for HADS-total; for Depression, optimal cut-offs were 4 for HADS-D, 11 for HADS-total, and 8 for MADRS. At cut-offs commonly used in clinical practice for depression screening (HADS-D: 8, MADRS: 12), the MADRS performed marginally better than the HADS. CONCLUSION: Anxiety is as prevalent as depression 4 months after stroke. MADRS and HADS-D perform acceptably as screening instruments for depression, and HADS-A for anxiety after stroke. However, lower HADS cut-offs than recommended for the general population should be considered for stroke patients.
OBJECTIVE:Anxiety and depression after stroke are frequent, but are often overlooked and not assessed. The aims of the study were to (1) assess the prevalence of anxiety and depression and (2) compare the performance of the Hospital Anxiety and Depression Scale (HADS) and Montgomery and Asberg Depression Rating Scale (MADRS) as screening instruments for anxiety and depression disorders 4 months after stroke. METHODS:Strokepatients, consecutively admitted to a stroke unit, were assessed with HADS and MADRS 4 months after stroke (n=104). Depression and anxiety disorders were diagnosed using the Structured Clinical Interview for DSM-IV (SCID). Measures were compared in terms of correlations, sensitivity, specificity, positive and negative predictive value, overall agreement, kappa, and ROC curves, using DSM-IV diagnoses of "at least one current significant anxiety disorder" (Anxiety) and "any current depression" (Depression), as the clinical criteria. RESULTS:Anxiety occurred in 23% of patients and Depression in 19% (13% major depression, 3% minor depression, 4% dysthymia). For Anxiety, the optimal screening cut-off was 4 for HADS-A and 6 for HADS-total; for Depression, optimal cut-offs were 4 for HADS-D, 11 for HADS-total, and 8 for MADRS. At cut-offs commonly used in clinical practice for depression screening (HADS-D: 8, MADRS: 12), the MADRS performed marginally better than the HADS. CONCLUSION:Anxiety is as prevalent as depression 4 months after stroke. MADRS and HADS-D perform acceptably as screening instruments for depression, and HADS-A for anxiety after stroke. However, lower HADS cut-offs than recommended for the general population should be considered for strokepatients.
Authors: Dalia Cahana-Amitay; Martin L Albert; Sung-Bom Pyun; Andrew Westwood; Theodore Jenkins; Sarah Wolford; Mallory Finley Journal: Aphasiology Date: 2011-04-19 Impact factor: 2.773
Authors: Nicholas Meader; Alex J Mitchell; Carolyn Chew-Graham; David Goldberg; Maria Rizzo; Victoria Bird; David Kessler; Jon Packham; Mark Haddad; Stephen Pilling Journal: Br J Gen Pract Date: 2011-12 Impact factor: 5.386
Authors: Judith Z Goldfinger; Donald Edmondson; Ian M Kronish; Kezhen Fei; Revathi Balakrishnan; Stanley Tuhrim; Carol R Horowitz Journal: J Stroke Cerebrovasc Dis Date: 2013-10-19 Impact factor: 2.136
Authors: Katharina S Sunnerhagen; Anna Danielsson; Lena Rafsten; Ann Björkdahl; Åsa B Axelsson; Åsa Nordin; Cathrine A Petersson; Åsa Lundgren-Nilsson; Karin Fröjd Journal: BMC Neurol Date: 2013-06-24 Impact factor: 2.474
Authors: Donald Edmondson; Safiya Richardson; Jennifer K Fausett; Louise Falzon; Virginia J Howard; Ian M Kronish Journal: PLoS One Date: 2013-06-19 Impact factor: 3.240
Authors: Felipe José Aidar; Ricardo Jacó de Oliveira; António José Silva; Dihogo Gama de Matos; Mauro Lúcio Mazini Filho; Robert C Hickner; Victor Machado Reis Journal: Stroke Res Treat Date: 2012-11-11